These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9923528)
1. Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS. Mirete G; Masiá M; Gutiérrez F; Mora A; Escolano C; Maestre A Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):810-1. PubMed ID: 9923528 [No Abstract] [Full Text] [Related]
2. Ritonavir, triglycerides, and pancreatitis. Perry RC; Cushing HE; Deeg MA; Prince MJ Clin Infect Dis; 1999 Jan; 28(1):161-2. PubMed ID: 10028103 [No Abstract] [Full Text] [Related]
4. [Ritonavir-boosted lopinavir monotherapy due to intolerance to nucleoside reverse transcriptase inhibitors in an HIV-infected paediatric patient]. Espiau M; Soler-Palacín P; Borrull A; Figueras C Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):319. PubMed ID: 21334110 [No Abstract] [Full Text] [Related]
5. Lipid lowering therapy in patients with HIV infection. McBride M; Chin MT; Lee SM; Kelly B Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377 [No Abstract] [Full Text] [Related]
6. Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine. De Wit S; Cassano P; Hermans P; Kabeya K; Gerard M; O'Doherty E; Clumeck N AIDS; 1999 May; 13(7):864-5. PubMed ID: 10357390 [No Abstract] [Full Text] [Related]
7. Stavudine-induced pancreatitis followed by lopinavir-ritonavir-induced pancreatitis: is co-trimoxazole the culprit? Bhargava P J Postgrad Med; 2008; 54(3):241; author reply 241-2. PubMed ID: 18626183 [No Abstract] [Full Text] [Related]
8. Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency. Thuret I; Michel G; Chambost H; Tamalet C; Giraud P; Brunet C; Perrimond H AIDS; 1999 Jan; 13(1):81-7. PubMed ID: 10207548 [TBL] [Abstract][Full Text] [Related]
9. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969 [TBL] [Abstract][Full Text] [Related]
10. HIV-protease inhibitors. Di Perri G; Del Bravo P; Concia E N Engl J Med; 1998 Sep; 339(11):773-4; author reply 774. PubMed ID: 9742031 [No Abstract] [Full Text] [Related]
11. Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons. Spear GT; Olinger G; Sullivan BL; Landay AL; Kessler H; Connick E; Kuritzkes D; St Clair M; Spritzler J; Wu H; Lederman MM AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1713-5. PubMed ID: 10606095 [No Abstract] [Full Text] [Related]
12. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial. Perez-Molina JA; Rubio R; Rivero A; Pasquau J; Suárez-Lozano I; Riera M; Estébanez M; Santos J; Sanz-Moreno J; Troya J; Mariño A; Antela A; Navarro J; Esteban H; Moreno S; Lancet Infect Dis; 2015 Jul; 15(7):775-84. PubMed ID: 26062881 [TBL] [Abstract][Full Text] [Related]
13. Ritonavir and indinavir one year later. TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094 [No Abstract] [Full Text] [Related]
15. Ritonavir and saquinavir combination therapy for the treatment of HIV infection. Cameron DW; Japour AJ; Xu Y; Hsu A; Mellors J; Farthing C; Cohen C; Poretz D; Markowitz M; Follansbee S; Angel JB; McMahon D; Ho D; Devanarayan V; Rode R; Salgo M; Kempf DJ; Granneman R; Leonard JM; Sun E AIDS; 1999 Feb; 13(2):213-24. PubMed ID: 10202827 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine. Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672 [TBL] [Abstract][Full Text] [Related]
17. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA; Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068 [TBL] [Abstract][Full Text] [Related]